Fountain TRT Review: The Rare Honest Headline, Priced in 28-Day Months

$199 every four weeks with no commitment, and that one figure covers the labs, the provider visits, the shipping and the medication — there is no membership charged beside the drug. Before any of it you pay a one-time $35 evaluation. If you are willing to pay up front, $499 buys twelve weeks and $1,799 buys forty-eight, which work out at $167 and $150 a term. The figure that surprises people is the annual one: because a Fountain month is four weeks, $199 a month is thirteen charges and $2,587 a year. Read off fountaintrt.com and its own checkout on August 9, 2026.

Because there is genuinely nothing to walk away from at $199 — it is the month-to-month rate, not a prepay rate wearing a monthly label. That makes Fountain unusual: most companies on this site advertise a figure that requires a three- or twelve-month commitment and charge more to anyone who does not commit. Fountain's cheaper rates exist, at $167 and $150, and it leaves them in the checkout. What the equality does not mean is that $199 is a low price or that the headline is accurate — calling a company's dearest rate "as low as" is still the wrong way round.

Because Fountain does not bill monthly and says so in its own checkout: "Membership months are based on 4 week intervals, because medications are dosed in weekly increments." Four weeks is thirteen charges a year rather than twelve, so the true annual figure is $2,587 rather than $2,388 — an extra $199 that no per-month figure on the site will ever show you. Its product catalogue is consistent about it: every term is written as "4 Weeks", "12 Weeks" or "48 Weeks", never as a month.

No, and it is the most likely thing to be misread on this site. The $35 is a one-time evaluation — labs plus a twenty-minute provider visit — and the page selling it strikes through "Normally $285" beside it while a banner announces an 88% discount. Fountain does disclose what comes next: "If prescribed, membership is $199/month." But every button on the site says $35, and treatment costs roughly six times that every four weeks. It is refundable only if you are not medically approved.

No, and it should not be compared with one. It is a programme price with the medication inside it, alongside the labs, the provider visits, the 24/7 support and the shipping — Fountain's own words are "All-inclusive: 24/7 concierge support, labs, provider visits, shipping, and medication." Set against a seller that charges $40 for a drug and $155 for a membership, the $199 is doing all of that work at once. That is why every row on this review is labelled a programme rather than a drug.

It serves thirty-five, and the list on its website is not the one to trust. That FAQ names twenty states — including Alabama and Connecticut — and Fountain's own eligibility software refuses both; we checked each twice with different ZIP codes. The same software accepts fifteen states the page never mentions. The page has not been modified since the last day of 2025, which is the likeliest explanation. Our list comes from the software rather than the page, and the two states Fountain advertises but does not serve are named as exclusions precisely because being told yes and then no is worse than being told no.

No. The live warning-letter index was queried on August 9, 2026 under "fountain trt", the condensed "fountaintrt", both corporate entities named in its own documents — Fountain Wellness and Fountain Vitality — and the medical practice named in its telehealth consent. Every pass returned zero rows with the returned count matching the filtered count. The broader term "fountain" returns three letters, and all three are name collisions we opened and rejected: two vape companies whose street address happens to be in Fountain Valley, California, and a supplement firm caught on a blog headline containing the phrase "Fountain-of-Youth". The screen was run with a positive control that returned SkinnyRx's February 2026 letter as a company-column match, and a close-out control on Belmar Pharma Solutions whose October 2023 close-out date appeared exactly where expected.